Monday, May 06, 2013 1:55:19 PM
They get to choose when to announce the product we sell them in terms of their own marketing priorities. They face tough competition and want to gain an edge in their own way.
Please note that in the past motivated investors have been able to determined some of our deals from simple internet research but it was not with our help so we did respect our confidentiality agreements.
What I can tell you is that two of our simpler mobile apps will be now distributed through a distribution company that serves more than 2000 drug stores across the US. These pharmacies reach some 20 million clients.
Our main app provides a secure access by mobile phone to the clients drug file at the pharmacy. It helps the client monitor his drugs, show them to other clinicians and help manage compliance. The other app provides a simple adequacy test on drugs verses diagnostics as a mean to provide clinical guidance for patients. Drug errors have emerged as a major cause of mortality and morbidity in America.
For the pharmacy this is part of a new wave of wellness product that should help cement the relationship with the client and build a sense of loyalty.
It is expected that these apps will have a particular appeal for mothers and the elderly.
VisualMED will collect 60 cent clear per prescription. The drug store is expected to charge $2.00 and pay $1.20 to the distribution company. The distributor estimates we will reach 10 million prescription by the end of year one.
It has taken us more than two years to find the right product and service that we can sell to drug stores. We are very encouraged by these developments.
I hope this answers your questions.
Thank you for your interest
Best Regards
Gerard Dab
Recent MVNT News
- Movement Industries Corporation Announces Joint Venture Alliance With an Excess of Ten Million Dollar Contract • InvestorsHub NewsWire • 06/29/2023 01:28:07 PM
FEATURED NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM